IMPACTT: Impact of a Patient Decision Aid Intervention
Study Details
Study Description
Brief Summary
Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered pre-consultation, but there are no randomised, controlled studies comparing the two. However, timing and format of the patient decision aid intervention may affect how useful the tool is to the patient. The aim of this project is therefore to deepen our understanding of the patient's engagement in and preparation for the decision making process in a randomised, controlled trial comparing an electronic pre-consultation and paper-based in-consultation patient decision aid. 274 patients with colorectal and breast cancer are enrolled in the study. Data are collected at both patient and consultant perceived levels as well as an observed level of shared decision making.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
A cancer diagnosis is life-changing and followed by complex decisions about treatment options. Often the decision about which treatment to choose is based on risks and benefits, although the benefit-harm ratios are unknown. In these situations, a patient decision aid can be helpful in explaining the options, clarifying the patient's preferences and acting as an adjunct to the clinician's counselling, supporting the patient in complex decisions about their diagnosis.
Studies evaluating patient decision aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered pre-consultation, but there are no randomised, controlled studies comparing the two. There is a lack of evidence of the impact of patient decison aids used pre-consultation versus in-consultation, as timing and format of the patient decision aid intervention may affect how useful the tool is to the patient. The aim of this project is therefore to deepen our understanding of the patient's engagement in and preparation for the decision making process in a randomised, controlled trial comparing a digital pre-consultation and paper-based in-consultation patient decision aid. 274 patients with colorectal and breast cancer are enrolled in the study. Data are collected at both patient and consultant perceived level as well as an observed level of shared decision making (SDM).
A secondary analysis of the data collected in the study will form the basis of a study testing the convergent validity of the patient-reported measures by comparing them to the observed level of patient involvement. During the last decade, the strong move towards increased SDM has led to development of several measurement scales, and there is a demand for convergent validity studies, as there is no gold standard to evaluate SDM behaviors. Previous validity studies have various shortcomings.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Arm A1: Breast cancer patients
|
Other: Pre-consultation electronic patient decision aid
This group is invited to access an electronic version before the consultation. The group of colorectal cancer patients is also introduced to a paper-based version by the clinician in the consultation.
|
| Active Comparator: Arm B1: Breast cancer patients
|
Other: In-consultation paper-based patient decision aid
This group is introduced to a paper-based version by the clinician in the consultation
|
| Experimental: Arm A2: Colorectal cancer patients
|
Other: Pre-consultation electronic patient decision aid
This group is invited to access an electronic version before the consultation. The group of colorectal cancer patients is also introduced to a paper-based version by the clinician in the consultation.
|
| Active Comparator: Arm B2: Colorectal cancer patients
|
Other: In-consultation paper-based patient decision aid
This group is introduced to a paper-based version by the clinician in the consultation
|
Outcome Measures
Primary Outcome Measures
- Level of involvement of patients in shared decision making (breast cancer) [Within one week after the consultation]
4-item Shared Decision Making Process Scale (SDM Process 4) with patient-reported measures of the amount of shared decision making that occurs around the medical decision. Score range is 0 to 4 points, a higher score indicates more involvement in the decision.
- Observed level of patient involvement in decision making according to the OPTION5 tool (colorectal cancer) [Through study completion, an average of 3 months]
settings (OPTION5). Scores range 0-100. Higher score indicates higher patient involvement in decision making.
Secondary Outcome Measures
- Patient-perceived level of shared decision making (breast and colorectal cancer) [Within one week after the consultation]
9-item Shared Decision Making Questionnaire (SDM-Q-9) that measures the extent to which patients are involved in the process of decision-making from the perspective of the patient. Scores range from 1 to 6 on each question. The total score range is thus 9-54 with 54 as the best score indicating higher involvement.
- Patient-perceived level of shared decision making between patient and consultant (breast and colorectal cancer) [Within one week after the consultation]
3-item questionnaire (CollaboRATE) with patient-reported measures of the perception of being informed and involved in decision making. Each item is scored on a 0 to 9 scale on a 10-point Likert scale, a higher score indicates a better experience.
- Level of patient preparation for decision making (breast and colorectal cancer) [Within one week after the consultation]
10-item questionnaire (Preparation for Decision Making Scale) with patient-reported measures of how useful the decision aid / decision support intervention is in preparing the patient for the consultation. The scale is from 1 (not at all useful) to 5 (very useful). Higher scores indicate greater preparation.
- Level of decisional conflict (breast and colorectal cancer) [Before consultation and within one week after the consultation]
16-item questionnaire (Decisional conflict scale) with patient-reported measures of uncertainty and decisional conflict. Each item is rated on a 5-point scale, and total scores are calculated by summing the raw scores of all items and presenting them on a scale of 0-100, with higher scores indicating greater decision conflict. Scores greater than 25 indicate clinically important decisional conflict.
- Degree of control over the decision about medical treatment (breast and colorectal cancer) [Before the consultation]
1-item questionnaire (Control Preference Scale) with a patient-reported measure of the degree of control that the patient wants to assume when decisions are being made about medical treatment. Answers range from Fully active role, Semiactive role, Collaborative role, Semipassive role and Fully passive role.
- Consultant-perceived level of shared decision making (breast and colorectal cancer) [Within one week after the consultation]
9-item Shared Decision Making Questionnaire (SDM-Q-doc) that measures the extent to which patients are involved in the process of decision-making from the perspective of the consultant. The items are scored from 0 to 5 on a six-point Likert scale ranging from "completely disagree" (0) to "completely agree" (5). A linear transformation of item score sum yields a transformed score (0-100), with higher values indicating more shared decision making.
- Observed level of patient involvement in decision making according to the OPTION5 tool (breast cancer) [Through study completion, an average of 3 months]
Measuring shared decision making by assessing recordings of encounters from clinical settings (OPTION5). Scores range 0-100. Higher score indicates higher patient involvement in decision making.
- Level of involvement of patients in shared decision making (colorectal cancer) [Within one week after the consultation]
4-item Shared Decision Making Process Scale (SDM Process 4) with patient-reported measures of the amount of shared decision making that occurs around the medical decision. Score range is 0 to 4 points, a higher score indicates more involvement in the decision.
Other Outcome Measures
- Consultation length measured in minutes [Through study completion, an average of 3 months]
Length of consultation in minutes
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Histologically verified breast or colorectal cancer
-
Age ≥ 18 years
Exclusion Criteria:
-
Unable to read Danish
-
Not the owner/user of a mobile smartphone
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Lillebaelt Hospital | Vejle | Denmark |
Sponsors and Collaborators
- Vejle Hospital
- The Ottawa Hospital Research Institute
Investigators
- Study Chair: Karina Dahl Steffensen, Sygehus Lillebaelt
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IMPACTT